About Us

Background

Cancer is the third-leading cause of disease-related mortality in Malaysia and Southeast Asia, following behind cardiovascular, and respiratory diseases. Many cancers in this region and other low to middle-income countries (LMICs) are diagnosed at an advanced stage due to lower health literacy, late presentation, limited population screening and surveillance program, absence of robust patient navigation system, the difficulty of access to comprehensive cancer care, prohibitively expensive innovative cancer treatments, and limited access to new clinical trials.

There have been many initiatives locally to bridge these gaps. In order to improve cancer survival and the interventional impacts at a population level, we need integrated cancer care, research, and innovation ecosystem. More than ever, the pandemic has called for a bold approach to tackling these problems and has motivated the establishment of this social business.